Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

528
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
528
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

4.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

285
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
285
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Lipid Digestion01:06

Lipid Digestion

98.4K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study].

Giornale italiano di cardiologia (2006)·2026
Same author

Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside.

Circulation research·2026
Same author

[Fish Oil for the Heart? The Role of Omega-3 Fatty Acids in Cardiovascular Medicine].

MMW Fortschritte der Medizin·2026
Same author

MMW Fortschritte der Medizin·2026
Same author

Lipid Therapy in Patients with Diabetes Mellitus.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

MMW Fortschritte der Medizin·2026

Related Experiment Video

Updated: Jan 3, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.6K

Clinical review on triglycerides.

Ulrich Laufs1, Klaus G Parhofer2, Henry N Ginsberg3

  • 1Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, Leipzig, Germany.

European Heart Journal
|November 26, 2019
PubMed
Summary
This summary is machine-generated.

Hypertriglyceridaemia, high triglyceride levels, increases cardiovascular disease and pancreatitis risk. Management involves lifestyle changes, established therapies like fibrates and omega-3s, and emerging biological agents.

Keywords:
HypertriglyceridaemiaLipoproteinsReviewTreatmentTriglycerides

More Related Videos

Profiling the Triacylglyceride Contents in Bat Integumentary Lipids by Preparative Thin Layer Chromatography and MALDI-TOF Mass Spectrometry
09:18

Profiling the Triacylglyceride Contents in Bat Integumentary Lipids by Preparative Thin Layer Chromatography and MALDI-TOF Mass Spectrometry

Published on: September 5, 2013

21.7K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.7K

Related Experiment Videos

Last Updated: Jan 3, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.6K
Profiling the Triacylglyceride Contents in Bat Integumentary Lipids by Preparative Thin Layer Chromatography and MALDI-TOF Mass Spectrometry
09:18

Profiling the Triacylglyceride Contents in Bat Integumentary Lipids by Preparative Thin Layer Chromatography and MALDI-TOF Mass Spectrometry

Published on: September 5, 2013

21.7K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.7K

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Lipid Metabolism

Background:

  • Hypertriglyceridaemia is a prevalent clinical issue.
  • Triglyceride-rich lipoproteins (TRL) and their remnants are key contributors to atherosclerotic cardiovascular disease (ASCVD).
  • Severe hypertriglyceridaemia significantly elevates the risk of pancreatitis.

Purpose of the Study:

  • To review current understanding and management strategies for hypertriglyceridaemia.
  • To highlight the role of TRL in ASCVD and pancreatitis risk.
  • To discuss established and emerging therapeutic interventions.

Main Methods:

  • Literature review of epidemiologic and genetic studies.
  • Analysis of current clinical guidelines for lipid-lowering therapy.
  • Discussion of various treatment modalities for hypertriglyceridaemia.

Main Results:

  • Low-density lipoprotein (LDL) is the primary treatment target, but secondary targets like apoB and non-HDL-C are recommended.
  • Reducing severely elevated triglycerides is crucial for preventing pancreatitis.
  • Diet, lifestyle modifications, fibrates, omega-3 fatty acids, and novel biological agents are discussed.

Conclusions:

  • Hypertriglyceridaemia poses significant ASCVD and pancreatitis risks.
  • Comprehensive management strategies are essential, incorporating lifestyle, established, and emerging therapies.
  • Targeting TRL contributes to effective lipid management and risk reduction.